|
UPF3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.622400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.355800E-01 |
| Normal-vs-Stage2 |
7.470400E-01 |
| Normal-vs-Stage3 |
6.749400E-01 |
| Normal-vs-Stage4 |
1.871010E-01 |
| Stage1-vs-Stage2 |
5.223000E-01 |
| Stage1-vs-Stage3 |
2.121400E-01 |
| Stage1-vs-Stage4 |
4.384200E-01 |
| Stage2-vs-Stage3 |
9.200600E-01 |
| Stage2-vs-Stage4 |
3.836800E-01 |
| Stage3-vs-Stage4 |
1.340970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.150800E-01 |
| Normal-vs-AfricanAmerican |
9.552000E-01 |
| Normal-vs-Asian |
5.670200E-01 |
| Caucasian-vs-AfricanAmerican |
7.641600E-01 |
| Caucasian-vs-Asian |
5.478600E-01 |
| AfricanAmerican-vs-Asian |
7.389600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.766400E-01 |
| Normal-vs-Female |
1.799580E-01 |
| Male-vs-Female |
1.152000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.557000E-01 |
| Normal-vs-Extreme_Weight |
4.418000E-01 |
| Normal-vs-Obese |
5.908200E-01 |
| Normal-vs-Extreme_Obese |
5.759200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.457000E-01 |
| Normal_Weight-vs-Obese |
4.074800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.792400E-01 |
| Extreme_Weight-vs-Obese |
1.861810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.775400E-01 |
| Obese-vs-Extreme_Obese |
3.282600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.565200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.859800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.390200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.346800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.369800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.299790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.245800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.978500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.505500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.436200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.284800E-01 |
| Normal-VS-Type2 PRCC |
5.410300E-02 |
| Normal-VS-KIRP CIMP |
9.776000E-01 |
| Normal-VS-Unclassified PRCC |
5.429000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.299100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.789200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.864000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.455800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.398110E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.857200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.441580E-01 |
| Normal-vs-N1 |
3.599200E-01 |
| Normal-vs-N2 |
9.224600E-01 |
| N0-vs-N1 |
5.708500E-02 |
| N0-vs-N2 |
6.983600E-01 |
| N1-vs-N2 |
7.610800E-01 |
|
|
